Carlo de Notaristefani
2019
Compensation breakdown
Non-Equity Incentive Plan | $780,445 |
---|---|
Salary | $836,400 |
Stock Awards | $2,499,982 |
Other | $202,011 |
Total | $4,318,838 |
de Notaristefani received $2.5M in stock awards, accounting for 58% of the total pay in 2019.
de Notaristefani also received $780.4K in non-equity incentive plan, $836.4K in salary and $202K in other compensation.
Rankings
In 2019, Carlo de Notaristefani's compensation ranked 2,695th out of 13,971 executives tracked by ExecPay. In other words, de Notaristefani earned more than 80.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,695 | 81st |
Manufacturing | 972 | 83rd |
Chemicals And Allied Products | 319 | 86th |
Drugs | 260 | 86th |
Pharmaceutical Preparations | 192 | 86th |
de Notaristefani's colleagues
We found six more compensation records of executives who worked with Carlo de Notaristefani at Teva Pharmaceutical Industries in 2019.
2019
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2019
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2019
Michael McClellan
Teva Pharmaceutical Industries
Chief Financial Officer
2019
Brendan O'Grady
Teva Pharmaceutical Industries
Executive Vice President, North America Commercial
2019
Gianfranco Nazzi
Teva Pharmaceutical Industries
Executive Vice President, International Markets Commercial
2019
Eli Kalif
Teva Pharmaceutical Industries